Published in Part Fibre Toxicol on January 20, 2010
Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol (2013) 1.67
Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. Environ Health Perspect (2011) 1.57
Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol (2013) 1.33
Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine (2011) 1.25
Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun (2013) 1.20
Submesothelial deposition of carbon nanoparticles after toner exposition: case report. Diagn Pathol (2010) 1.16
Nanoparticles in the lung. Nat Biotechnol (2010) 1.14
The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One (2012) 1.11
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Acc Chem Res (2012) 1.10
Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Part Fibre Toxicol (2010) 1.07
Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro. Nanotoxicology (2014) 1.03
An in vitro liver model--assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials. Part Fibre Toxicol (2012) 1.01
Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol (2014) 1.01
Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol (2013) 0.99
Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats. Beilstein J Nanotechnol (2013) 0.99
Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles. Part Fibre Toxicol (2014) 0.95
Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci (2014) 0.91
Brake wear particle emissions: a review. Environ Sci Pollut Res Int (2014) 0.90
Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles. Part Fibre Toxicol (2014) 0.88
Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation. Toxicol Sci (2015) 0.86
Rat pulmonary responses to inhaled nano-TiO₂: effect of primary particle size and agglomeration state. Part Fibre Toxicol (2013) 0.86
Advances in Inhalation Dosimetry Models and Methods for Occupational Risk Assessment and Exposure Limit Derivation. J Occup Environ Hyg (2015) 0.86
Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation. Part Fibre Toxicol (2013) 0.84
Darkfield-confocal microscopy detection of nanoscale particle internalization by human lung cells. Part Fibre Toxicol (2011) 0.84
Nanoparticle interactions with live cells: Quantitative fluorescence microscopy of nanoparticle size effects. Beilstein J Nanotechnol (2014) 0.83
Intratracheally instilled titanium dioxide nanoparticles translocate to heart and liver and activate complement cascade in the heart of C57BL/6 mice. Nanotoxicology (2015) 0.83
Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol (2013) 0.83
Innate Immune Responses to Nanoparticle Exposure in the Lung. J Environ Immunol Toxicol (2015) 0.83
Attenuation of Combined Nickel(II) Oxide and Manganese(II, III) Oxide Nanoparticles' Adverse Effects with a Complex of Bioprotectors. Int J Mol Sci (2015) 0.82
Subchronic toxicity of copper oxide nanoparticles and its attenuation with the help of a combination of bioprotectors. Int J Mol Sci (2014) 0.82
Gas-borne particles with tunable and highly controlled characteristics for nanotoxicology studies. Nanotoxicology (2012) 0.81
Real-Time Measurement of Electronic Cigarette Aerosol Size Distribution and Metals Content Analysis. Nicotine Tob Res (2016) 0.81
Platelet activation independent of pulmonary inflammation contributes to diesel exhaust particulate-induced promotion of arterial thrombosis. Part Fibre Toxicol (2016) 0.80
Particle deposition in a child respiratory tract model: in vivo regional deposition of fine and ultrafine aerosols in baboons. PLoS One (2014) 0.80
Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study. Part Fibre Toxicol (2014) 0.80
Possible role of nano-sized particles in chronic tonsillitis and tonsillar carcinoma: a pilot study. Eur Arch Otorhinolaryngol (2012) 0.79
Toxicity of nanoparticles embedded in paints compared with pristine nanoparticles in mice. Toxicol Sci (2014) 0.79
The use of (111)Ag as a tool for studying biological distribution of silver-based antimicrobials. Medchemcomm (2013) 0.79
Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: evidence of a beneficial effect on myoblast fusion. Int J Nanomedicine (2015) 0.79
No effect of acute exposure to coarse particulate matter air pollution in a rural location on high-density lipoprotein function. Inhal Toxicol (2014) 0.79
Some inferences from in vivo experiments with metal and metal oxide nanoparticles: the pulmonary phagocytosis response, subchronic systemic toxicity and genotoxicity, regulatory proposals, searching for bioprotectors (a self-overview). Int J Nanomedicine (2015) 0.78
Ultrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive rats. Part Fibre Toxicol (2014) 0.78
Differential pattern of deposition of nanoparticles in the airways of exposed workers. J Nanopart Res (2017) 0.77
Nanoparticle exposure reactivates latent herpesvirus and restores a signature of acute infection. Part Fibre Toxicol (2017) 0.77
Effect of aerosol particles generated by ultrasonic humidifiers on the lung in mouse. Part Fibre Toxicol (2013) 0.77
Exposure assessment and associated lung deposition calculations for vehicular exhaust in four metropolitan cities of Pakistan. Environ Monit Assess (2012) 0.77
Aerosolized Silver Nanoparticles in the Rat Lung and Pulmonary Responses over Time. Toxicol Pathol (2016) 0.77
Specific uptake and genotoxicity induced by polystyrene nanobeads with distinct surface chemistry on human lung epithelial cells and macrophages. PLoS One (2015) 0.77
Carbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicity. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.77
Progress and future of in vitro models to study translocation of nanoparticles. Arch Toxicol (2015) 0.76
TiO(2) nanoparticles and bulk material stimulate human peripheral blood mononuclear cells. Food Chem Toxicol (2013) 0.76
Quantification of Internalized Silica Nanoparticles via STED Microscopy. Biomed Res Int (2015) 0.76
Increase in oxidative stress levels following welding fume inhalation: a controlled human exposure study. Part Fibre Toxicol (2016) 0.76
Onset of alveolar recirculation in the developing lungs and its consequence on nanoparticle deposition in the pulmonary acinus. J Appl Physiol (1985) (2015) 0.75
Range-finding risk assessment of inhalation exposure to nanodiamonds in a laboratory environment. Int J Environ Res Public Health (2014) 0.75
Nano-technology and nano-toxicology. Emerg Health Threats J (2012) 0.75
Comment on Shvedova et al. (2016), "gender differences in murine pulmonary responses elicited by cellulose nanocrystals". Part Fibre Toxicol (2016) 0.75
Evaluating Adverse Effects of Inhaled Nanoparticles by Realistic In Vitro Technology. Nanomaterials (Basel) (2017) 0.75
Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure. Nanotoxicology (2016) 0.75
Nanoparticle uptake by airway phagocytes after fungal spore challenge in murine allergic asthma and chronic bronchitis. BMC Pulm Med (2014) 0.75
Two Cases of Tsunami Dust Pneumonia: Organizing Pneumonia Caused by the Inhalation of Dried Tsunami Sludge after the 2011 Great East Japan Earthquake. Intern Med (2016) 0.75
Combustion By-Products and their Health Effects--combustion engineering and global health in the 21st century: issues and challenges. Int J Toxicol (2014) 0.75
A living cell quartz crystal microbalance biosensor for continuous monitoring of cytotoxic responses of macrophages to single-walled carbon nanotubes. Part Fibre Toxicol (2011) 0.75
Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs). J Aerosol Med Pulm Drug Deliv (2014) 0.75
Air-liquid interface exposure to aerosols of poorly soluble nanomaterials induces different biological activation levels compared to exposure to suspensions. Part Fibre Toxicol (2016) 0.75
Surface modification does not influence the genotoxic and inflammatory effects of TiO2 nanoparticles after pulmonary exposure by instillation in mice. Mutagenesis (2016) 0.75
Aerosol generation and characterization of multi-walled carbon nanotubes exposed to cells cultured at the air-liquid interface. Part Fibre Toxicol (2016) 0.75
Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms. Part Fibre Toxicol (2016) 0.75
Tensiometric and Phase Domain Behavior of Lung Surfactant on Mucus-like Viscoelastic Hydrogels. ACS Appl Mater Interfaces (2016) 0.75
Discovery of unique and ENM- specific pathophysiologic pathways: Comparison of the translocation of inhaled iridium nanoparticles from nasal epithelium versus alveolar epithelium towards the brain of rats. Toxicol Appl Pharmacol (2016) 0.75
Development of Combining of Human Bronchial Mucosa Models with XposeALI® for Exposure of Air Pollution Nanoparticles. PLoS One (2017) 0.75
Poly-lactic acid nanoparticles (PLA-NP) promote physiological modifications in lung epithelial cells and are internalized by clathrin-coated pits and lipid rafts. J Nanobiotechnology (2017) 0.75
"Are we forgetting the smallest, sub 10 nm combustion generated particles?". Part Fibre Toxicol (2015) 0.75
Vectorization by nanoparticles decreases the overall toxicity of airborne pollutants. PLoS One (2017) 0.75
Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats. Part Fibre Toxicol (2017) 0.75
E-Liquid Autofluorescence can be used as a Marker of Vaping Deposition and Third-Hand Vape Exposure. Sci Rep (2017) 0.75
Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants. Int Arch Occup Environ Health (2017) 0.75
Discovery and ramifications of incidental Magnéli phase generation and release from industrial coal-burning. Nat Commun (2017) 0.75
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med (2006) 10.44
Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect (2000) 8.37
The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc (1984) 7.61
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer (2006) 5.75
Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation (2005) 4.71
Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect (2005) 3.57
Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP (1994) 3.56
Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A (2002) 3.54
Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A (2002) 3.49
Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol (1992) 3.22
Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol (1992) 3.07
Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev (2001) 3.01
Biodistribution of 1.4- and 18-nm gold particles in rats. Small (2008) 2.32
Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect (2001) 2.28
Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med (2002) 2.15
Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med (2002) 2.06
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target (2002) 2.02
Epidemiological evidence on health effects of ultrafine particles. J Aerosol Med (2002) 2.00
Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. Inhal Toxicol (2000) 1.99
Pathways of clearance in mouse lungs exposed to iron oxide aerosols. Anat Rec (1975) 1.95
Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol (2004) 1.95
Cardiovascular effects of fine and ultrafine particles. J Aerosol Med (2005) 1.87
Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med (2007) 1.83
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Sampling designs for stereology. J Microsc (1981) 1.72
Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med (2005) 1.72
Ultrafine particle-lung interactions: does size matter? J Aerosol Med (2006) 1.69
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol (2006) 1.65
Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol (1990) 1.60
Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol (2006) 1.58
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol (2007) 1.56
Exposure to diesel exhaust induces changes in EEG in human volunteers. Part Fibre Toxicol (2008) 1.54
Pulmonary sumps, dust accumulations, alveolar fluid and lymph vessels. Acta Anat (Basel) (1955) 1.49
Dosimetry and toxicology of ultrafine particles. J Aerosol Med (2004) 1.41
Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy. Anat Rec (1971) 1.40
Cardiopulmonary mortality and air pollution. Lancet (2002) 1.39
Dose response of the pulmonary macrophagic system to various particulates and its relationship to transepithelial passage of free particles. Exp Lung Res (1981) 1.39
Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J Appl Physiol (1985) (2003) 1.38
Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol (1996) 1.35
Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol (2007) 1.30
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci (2005) 1.29
A review of recent methods for efficiently quantifying immunogold and other nanoparticles using TEM sections through cells, tissues and organs. Ann Anat (2008) 1.23
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation (2004) 1.22
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol (2004) 1.22
A novel exposure system for the efficient and controlled deposition of aerosol particles onto cell cultures. Environ Sci Technol (2008) 1.16
Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J (2006) 1.12
Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv (2008) 1.11
Presence of asbestos bodies in organs other than the lung. Chest (1980) 1.10
Morphological aspects of particle uptake by lung phagocytes. Microsc Res Tech (2002) 1.09
Electron energy loss spectroscopy for analysis of inhaled ultrafine particles in rat lungs. Microsc Res Tech (2004) 1.09
Tracheobronchial airway structure as revealed by casting techniques. Am Rev Respir Dis (1983) 1.07
Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: a critical review. Inhal Toxicol (2000) 1.06
Mucous blanket of rat bronchus: an ultrastructural study. Am Rev Respir Dis (1976) 1.06
A microanalytic study of particles transport across the alveoli: role of blood platelets. Biomedicine (1977) 1.05
Ultrastructure of lungs fixed in inflation using a new osmium-fluorocarbon technique. J Ultrastruct Res (1976) 1.04
Frequency of black pigment in livers and spleens of coal workers: correlation with pulmonary pathology and occupational information. Hum Pathol (1982) 1.03
No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol (2006) 1.03
Assessment of particle retention and clearance in the intrapulmonary conducting airways of hamster lungs with the fractionator. J Microsc (1990) 1.02
Alveolar macrophage-particle relationships during lung clearance. Am J Respir Cell Mol Biol (1989) 1.02
Airway macrophages. The importance of the fixation method. Am Rev Respir Dis (1984) 1.00
The effect of particle inhalation on macrophage number and phagocytic activity in the intrapulmonary conducting airways of hamsters. Am J Respir Cell Mol Biol (1994) 0.98
Air pollution and health - good news and bad. N Engl J Med (2004) 0.98
A novel quantitative method for analyzing the distributions of nanoparticles between different tissue and intracellular compartments. J Aerosol Med (2007) 0.97
Preservation of tracheal mucus by nonaqueous fixative. Biotech Histochem (1991) 0.97
Association of 59iron oxide with alveolar macrophages during alveolar clearance. Exp Lung Res (1985) 0.96
Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the "relative deposition index": Evidence for clearance through microvasculature. Part Fibre Toxicol (2007) 0.96
Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol (2000) 0.94
Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology (2006) 0.93
Effect of bronchopulmonary lavage on lung retention and clearance of particulate material in hamsters. Environ Health Perspect (1992) 0.91
Anatomic localization of 24- and 96-h particle retention in canine airways. J Appl Physiol (1985) (1999) 0.91
Efficiency of airway macrophage recovery by bronchoalveolar lavage in hamsters: a stereological approach. Eur Respir J (1995) 0.89
Influence of airspace geometry and surfactant on the retention of man-made vitreous fibers (MMVF 10a). Environ Health Perspect (2003) 0.88
Retention of Teflon particles in hamster lungs: a stereological study. J Aerosol Med (2000) 0.87
Estimation of particle number by stereology: an update. J Aerosol Med (2004) 0.86
Interaction of fungal spores with the lungs: distribution and retention of inhaled puffball (Calvatia excipuliformis) spores. J Allergy Clin Immunol (2000) 0.85
A biomathematical model of particle clearance and retention in the lungs of coal miners. II. Evaluation of variability and uncertainty. Regul Toxicol Pharmacol (2001) 0.85
Metabolic fate of inhaled Co aerosols in beagle dogs. Health Phys (1986) 0.84
Ultrastructure of the aqueous lining layer in hamster airways: is there a two-phase system? Microsc Res Tech (1997) 0.84
Studies of tantalum dust in the lungs. Radiology (1974) 0.84
Pathways of cellular efflux and particulate clearance after carbon instillation to the lung. J Pathol (1984) 0.83
Total and regional deposition of ultrafine particles in a mouse model of allergic inflammation of the lung. Inhal Toxicol (2008) 0.82
An improved method for fixation of the respiratory epithelial surface with the mucous and surfactant layers. Lab Invest (1982) 0.80
Migratory behaviors of alveolar macrophages during the alveolar clearance of light to heavy burdens of particles. Exp Lung Res (1990) 0.77
Biodistribution of 1.4- and 18-nm gold particles in rats. Small (2008) 2.32
Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med (2007) 1.83
Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials (2010) 1.77
Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: a multicenter approach. Environ Health Perspect (2004) 1.70
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol (2007) 1.56
Health effects of particles in ambient air. Int J Hyg Environ Health (2004) 1.55
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol (2009) 1.35
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm (2010) 1.29
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology (2011) 1.19
Nanoparticles in the lung. Nat Biotechnol (2010) 1.14
Concentration response functions for ultrafine particles and all-cause mortality and hospital admissions: results of a European expert panel elicitation. Environ Sci Technol (2010) 1.12
No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol (2006) 1.03
Nanoparticle delivery in infant lungs. Proc Natl Acad Sci U S A (2012) 0.98
Postnatal lung function in the developing rat. J Appl Physiol (1985) (2008) 0.97
Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review. J Aerosol Med Pulm Drug Deliv (2013) 0.96
The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials (2013) 0.95
Relationship between different size classes of particulate matter and meteorology in three European cities. J Environ Monit (2005) 0.93
Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. J Aerosol Med Pulm Drug Deliv (2012) 0.91
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology. Health Phys (2015) 0.91
Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology (2013) 0.89
Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. J Aerosol Med Pulm Drug Deliv (2009) 0.89
The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur J Pharm Biopharm (2010) 0.89
Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calcium. Part Fibre Toxicol (2005) 0.88
Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part Fibre Toxicol (2013) 0.88
The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol (2005) 0.85
Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci (2012) 0.85
Binding of polystyrene and carbon black nanoparticles to blood serum proteins. Inhal Toxicol (2011) 0.84
Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E(2 )synthesis: In vitro and in vivo studies. Part Fibre Toxicol (2009) 0.84
Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol (2013) 0.83
Efficient internalization and intracellular translocation of inhaled gold nanoparticles in rat alveolar macrophages. Nanomedicine (Lond) (2012) 0.83
Source apportionment of ambient fine particle size distribution using positive matrix factorization in Erfurt, Germany. Sci Total Environ (2008) 0.83
Cardiovascular and inflammatory effects of intratracheally instilled ambient dust from Augsburg, Germany, in spontaneously hypertensive rats (SHRs). Part Fibre Toxicol (2010) 0.82
Deep pulmonary lymphatics in immature lungs. J Appl Physiol (1985) (2009) 0.82
Corrections in dose assessment of 99mTc radiolabeled aerosol particles targeted to central human airways using planar gamma camera imaging. J Aerosol Med Pulm Drug Deliv (2009) 0.81
Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols. PLoS One (2013) 0.81
The procoagulant effects of fine particulate matter in vivo. Part Fibre Toxicol (2011) 0.78
Motion and twisting of magnetic particles ingested by alveolar macrophages in the human lung: effect of smoking and disease. Biomagn Res Technol (2006) 0.78
Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis. Part Fibre Toxicol (2014) 0.77